The influence of insulin sensitivity and glucose tolerance on the effects of antiviral
therapy for HCV remains unclear. The aim of the present study was (1) To elucidate the
clinical and virological factors associated with sustained viral response in patients with
combination therapy with PEG-IFN and ribavirin. (2) To clarify the influence of diabetes
mellitus (DM), impaired glucose tolerance test (IGT) and insulin resistance (IR) on the HCV
response to combination therapy with PEG-IFN and ribavirin. (3) To test the influence of
combination therapy on HOMA IR
Phase:
N/A
Details
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital